Skip to main content
Log in

Molecular mechanisms of antitumor activity of the polymeric form of niclosamide with respect to human colorectal cancer cells

  • Published:
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry Aims and scope Submit manuscript

Abstract

Using poly(lactic-co-glycolic) acid a polymeric form of niclosamide (PFN) has been developed and its antitumor activity against human colorectal cancer cell lines SW837, Caco-2, COLO 320 HSR has been investigated in comparison with free niclosamide. PFN was shown to be more cytotoxic against cancer cells and less cytotoxic against normal cells (human embryonic lung fibroblasts) as compared to niclosamide. Free niclosamide and PFN share a common mechanism of the cytotoxic action on tumor cells, which is associated with mitochondrial damage (evaluated as a decrease in rhodamine 123 accumulation), and increased levels of reactive oxygen species, particularly mitochondrial superoxide anion, causing oxidative damage of intracellular targets. The action of niclosamide and PFN was accompanied by G0/G1 cell cycle arrest.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wen, S., Zhu, D., and Huang, P., Future Med. Chem., 2013, vol. 5, no. 1, pp. 53–67. doi 10.4155/fmc.12.190

    Article  CAS  Google Scholar 

  2. Moskaleva, E.Yu., Perevozchikova, V.G., Zhirnik, A.S., and Severin, S.E., Biomed. Khim., 2015, vol. 61, pp. 680–693. doi 10.18097/pbmc20156106680

    Article  CAS  Google Scholar 

  3. Jin, Y., Lu, Z., Ding, K., Li, J., Du, X., Chen, C., Sun, X., Wu, Y., Zhou, J., and Pan, J., Cancer Res., 2010, vol. 70, no. 6, pp. 2516–2527. doi 10.1158/0008-5472.CAN-09-3950

    Article  CAS  Google Scholar 

  4. Khanim, F.L., Merrick, B.A., Giles, H.V., Jankute, M., Jackson, J.B., Giles, L.J., Birtwistle, J., Bunce, C.M., and Drayson, M.T., Blood Cancer J., 2011, vol. 1, no 10, e39. doi 10.1038/bcj.2011.38

    Article  CAS  Google Scholar 

  5. Zhao, J., He, Q., Gong, Z., Chen, S., and Cui, L., SpringerPlus, 2016, vol. 5, no. 1, p. 1436. doi 10.1186/s40064-016-3153-x

    Article  Google Scholar 

  6. Ye, Y., Zhang, X., Zhang, T., Wang, H., and Wu, B., Drug Dev. Ind. Pharm., 2015, vol. 41, no. 9, pp. 1416–1424. doi 10.3109/03639045.2014.954585

    Article  CAS  Google Scholar 

  7. Lin, C.K., Bai, M.Y., Hu, T.M., Wang, Y.C., Chao, T.K., Weng, S.J., Huang, R.L., Su, P.H., and Lai, H.C., Oncotarget, 2016, vol. 7, no. 8, pp. 8993–9006. doi 10.18632/oncotarget.7113

    Article  Google Scholar 

  8. Kumar, S.U. and Gopinath, P., Colloids Surf. B. Biointerfaces, 2015, vol. 131, pp. 170–181. doi 10.1016/j.colsurfb. 2015.04.063

    Article  CAS  Google Scholar 

  9. Misra, S.K., Jensen, T.W., and Pan, D., Nanoscale, 2015, vol. 7, no. 16, pp. 7127–7132. doi 10.1039/c5nr00403a

    Article  CAS  Google Scholar 

  10. Ostadhossein, F., Misra, S.K., Mukherjee, P., Ostadhossein, A., Daza, E., Tiwari, S., Mittal, S., Gryka, M.C., Bhargava, R., and Pan, D., Small, 2016, doi 10.1002/smll.201601161

    Google Scholar 

  11. Russo, A., Pellosi, D.S., Pagliara, V., Milone, M.R., Pucci, B., Caetano, W., Hioka, N., Budillon, A., Ungaro, F., Russo, G., and Quaglia, F., Int. J. Pharm., 2016, vol. 511, no. 1, pp. 127–139. doi 10.1016/j.ijpharm.2016.06.118

    Article  CAS  Google Scholar 

  12. Kuznetsova, I.G. and Severin, S.E., Razrabotka i Registratsiya Lekarstvennykh Sredstv, 2013, vol. 5, no. 5, pp. 30–36.

    Google Scholar 

  13. Lu, J.M., Wang, X., Marin-Muller, C., Wang, H., Lin, P.H., Yao, Q., and Chen, C., Expert Rev. Mol. Diagn., 2009, vol. 9, no. 4, pp. 325–341. doi 10.1586/erm.09.15

    Article  CAS  Google Scholar 

  14. Mosmann, T., J. Immunol. Methods, 1983, vol. 65, no. 1–2, pp. 55–63.

    Article  CAS  Google Scholar 

  15. Zhirnik, A.S., Semochkina, Yu.P., Moskaleva, E.Yu., Perevozchikova, V.G., Rodina, A.V., and Severin, S.E., Khimiko-Farmatsevticheskii Zhurnal, 2016, vol. 50, no. 7, pp. 40–43.

    Google Scholar 

  16. Kim, M., Cooper, D.D., Hayes, S.F., and Spangrude, G.J., Blood, 1998, vol. 91, no. 11, pp. 4106–4117.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. S. Zhirnik.

Additional information

Original Russian Text © A.S. Zhirnik, Yu.P. Semochkina, E.Yu. Moskaleva, N.I. Krylov, I.A. Tubasheva, S.L. Kuznetsov, E.A. Vorontsov, 2017, published in Biomeditsinskaya Khimiya.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhirnik, A.S., Semochkina, Y.P., Moskaleva, E.Y. et al. Molecular mechanisms of antitumor activity of the polymeric form of niclosamide with respect to human colorectal cancer cells. Biochem. Moscow Suppl. Ser. B 11, 301–307 (2017). https://doi.org/10.1134/S1990750817030131

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1990750817030131

Keywords

Navigation